Please: Login/Register

The Latest Edition of "Eyes on malaria" magazine will be out very soon!! | CALL FOR ARTICLES: AMMREN is inviting journalists / writers / scientists interested in reporting on malaria to send articles for publication in its international magazine “Eyes on Malaria” and for posting on its website. Please contact the AMMREN Secretariat for more details click here. Enjoy your stay!. Volunteers and interns urgently needed to work with an NGO working in the area of malaria and health. Apply through - / Journalists interested in reporting on and writing articles on health issues should please reply through this email:




    Mosquitoes around the home can be reduced significantly by minimizing the amount of standing water available for mosquito breeding. Residents are urged to reduce standing water around the home in a variety of ways.


    The best way is to avoid being bitten by mosquitoes.This can be accomplished using personal protecting  while outdoors when mosquitoes are present. Treated bed nets should be used sleeping. Mosquito repellent should be used when outdoor.


    Nearly half of the world’s population is at risk of getting malaria. Pregnant women are particularly at risk of malaria. Children under 5 years are at high risk of malaria.


  • First Edition

  • Second Edition

  • Third Edition

  • Fourth Edition

  • Fifth Edition

  • Sixth Edition

  • Seventh Edition

  • Eighth Edition

  • Ninth Edition

  • Special Edition

  • INESS Edition

  • Tenth Edition

  • INDEPTH Edition

  • Eleventh Edition

  • Twelfth Edition

  • Special Edition

  • Special Edition

  • Volume 1

Special Edition's Editorial

This is a Special Edition of Eyes on Malaria dedicated to the INDEPTH Effectiveness and Safety Studies of antimalarials (INESS) in Africa.

INESS is a project established to provide objective evidence on the safety and effectiveness of new anti-malarial drugs as a basis for malaria treatment policy. The INESS project is being run in Tanzania, Ghana, Burkina Faso and Mozambique.

The project is primarily intended to help strengthen Health and Demographic Surveillance System (HDSS) sites in those countries to become a platform suitable for monitoring safety and community effectiveness of new medical products including malaria control interventions such as drugs, vector control tools and vaccines.

To date, over thirty thousand patients have been followed up in Ghana and Tanzania. Institutions were monitored in their day to day operations to document good practices and find ways of addressing bad practices in the management of malaria.

INESS researchers have shown with hard evidence that artemisinin-based combination therapies (ACTs) drugs are very potent. However, it was observed with dismay that effective and efficacious drugs need very effective health delivery system in order to perform as expected.

The problem with the sub-Saharan health sector is such that drugs lose their effectiveness substantially through a host of factors. Non-compliance of health personnel to laid-down regulations and the inconsistency of patient adherence to prescriptions are among the identified problems in the health system.

In extreme circumstances, people who need the malaria drugs to save their lives, have no access to the drugs, due to what is referred to as the “system’s ineffectiveness.”

INESS has shown that the quest to overcome malaria ought to be driven by the realisation that its prevention, diagnosis and treatment must be complemented with a robust surveillance system to make the interventions effective.

Through regular visits to the homes of patients receiving treatment, the introduction of finger printing with identity cards and the sharing of patients’basic health and demographic data with other sectors, INESS researchers helped show what it entails to provide better health care.

It is the hope of researchers and stakeholders that large-scale Phase 4 studies like INESS will be encouraged and funded by the very countries which are vulnerable to malaria.

The harsh reality is that the disease still claims over 600 thousand lives a year, which requires serious   attention.

The encouraging development however is that researchers are showing the right way to win the fight.

Editorial Team
Charity Binka     Managing Editor
Carlton Cofie      Editor
Eunice Menka    Assistant Editor


Iness Edition